Inventor
ZHU LIUSHENG
US34 patents
⚠️ This page may combine multiple inventors who share the name “ZHU LIUSHENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORIC PHARMACEUTICALS INC
14 patentsUS11028120B2Jun 8, 2021
CD73 inhibitors
ORIC PHARMACEUTICALS INC10 citations93
US12018043B2Jun 25, 2024
CD73 inhibitors
ORIC PHARMACEUTICALS INC6 citations85
US11325938B2May 10, 2022
CD73 inhibitors
ORIC PHARMACEUTICALS INC9 citations85
US11530236B2Dec 20, 2022
CD73 inhibitors
ORIC PHARMACEUTICALS INC4 citations83
US11130778B2Sep 28, 2021
CD73 inhibitors
ORIC PHARMACEUTICALS INC8 citations83
US10472387B2Nov 12, 2019
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC2 citations73
US12577272B2Mar 17, 2026
CD73 inhibitors
ORIC PHARMACEUTICALS INC0 citations62
US12454544B2Oct 28, 2025
CD73 inhibitors
ORIC PHARMACEUTICALS INC0 citations62
US11807658B2Nov 7, 2023
CD73 inhibitors
ORIC PHARMACEUTICALS INC1 citations62
US11124537B2Sep 21, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC1 citations61
US11208432B2Dec 28, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US11110103B2Sep 7, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US10836789B2Nov 17, 2020
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US10723759B2Jul 28, 2020
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
AMGEN INC
10 patentsUS7144903B2Dec 5, 2006
CCR4 antagonists
AMGEN INC90 citations95
US6884782B2Apr 26, 2005
STAT modulators
AMGEN INC23 citations92
US8030354B2Oct 4, 2011
Substituted biphenyl GPR40 modulators
AMGEN INC11 citations83
US7816367B2Oct 19, 2010
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
AMGEN INC15 citations83
US7649110B2Jan 19, 2010
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
AMGEN INC8 citations83
US7582803B2Sep 1, 2009
Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
AMGEN INC17 citations83
US10100063B2Oct 16, 2018
Compounds that inhibit Mcl-1 protein
AMGEN INC8 citations82
US11306107B2Apr 19, 2022
Compounds that inhibit MCL-1 protein
AMGEN INC2 citations71
US7465804B2Dec 16, 2008
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
AMGEN INC3 citations63
US10836779B2Nov 17, 2020
Compounds that inhibit MCL-1 protein
AMGEN INC0 citations51
NURA BIO INC
5 patentsUS11629136B1Apr 18, 2023
Substituted pyridine derivatives as SARM1 inhibitors
NURA BIO INC4 citations70
US11970481B1Apr 30, 2024
Substituted pyridine derivatives as SARM1 inhibitors
NURA BIO INC4 citations67
US11945796B2Apr 2, 2024
Substituted pyridine derivatives as SARM1 inhibitors
NURA BIO INC2 citations67
US12110285B2Oct 8, 2024
Substituted pyridine derivatives as SARM1 inhibitors
NURA BIO INC1 citations58
US12404265B2Sep 2, 2025
Substituted pyridine derivatives as SARM1 inhibitors
NURA BIO INC0 citations55